Dr. Ron Golan, MD

Dr. Golan practices at Foothill Surgery Center at Sansum Clinic in Santa Barbara, California.

Dr. Golan's NPI, 1861835852, was assigned on April 10, 2013. Dr. Golan graduated from Perelman School of Medicine - Philadelphia in 2013. Dr. Golan's New York license number on file is 296290.

Dr. Golan's primary practice is Foothill Surgery Center at Sansum Clinic, at 4151 Foothill Road, Santa Barbara, CA 93110. The practice phone is (805) 681-1760.

Dr. Golan's primary practice is Foothill Surgery Center at Sansum Clinic in Santa Barbara, California. Dr. Golan is also affiliated with Santa Barbara Cottage Hospital. The medical group on file is Sansum Clinic. Dmand AI also links Dr. Golan to 3 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Golan practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Golan's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Golan is board certified in urology by the American Board of Urology. Dmand AI has Dr. Golan's licenses on file in 2 states: New York and California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Golan treats.

CMS data shows 8,215 Medicare services from Dr. Golan across 30 procedure codes in 2024, for 865 Medicare patients. Medicare paid $261,954 for them.

CMS counts 865 Medicare patients who saw Dr. Golan in 2024. The largest group is 65 to 74, with 419 patients. 71% of them have high cholesterol, and 65% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Golan's median patient age at 72, with 16% women.

In 2024, Dr. Golan wrote 1,734 Medicare Part D claims for 628 patients. 84% of them were for generic drugs. CMS names the drug for 1,679 of them, across 24 drugs with 11 or more claims each, at $286,329 in total drug cost. In 2023, CMS named 1,473 claims across 19 drugs.

Dr. Golan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Golan as offering telehealth. CMS counts 28 procedures of prostate resection by Dr. Golan, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 23 papers to Dr. Golan, published from 2014 to 2022. 2017 was the busiest year, with 8. The most frequent topics are Prostatic Neoplasms, SEER Program and Biomarkers, Tumor. Dr. Golan has published most often in Urology. Dr. Golan's most frequent co-authors are Jim C. Hu, MD, MPH, Ojas Shah, MD and Christopher E. Barbieri, MD, PhD.

CMS Open Payments shows 114 general payments to Dr. Golan from 26 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 86% of the total. Coloplast Corp paid the most, $1,463.

Dr. Golan graduated from Perelman School of Medicine - Philadelphia in 2013. Dr. Golan is a member of American Board of Urology.

Dr. Golan is in network with 12 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.